Search

Maud J Urbanski

age ~71

from Flemington, NJ

Also known as:
  • Maud A Urbanski
  • Maude J Urbanski
  • Maud Urdanski
Phone and address:
14 Mcpherson Dr, Flemington, NJ 08822
908 284-1770

Maud Urbanski Phones & Addresses

  • 14 Mcpherson Dr, Flemington, NJ 08822 • 908 284-1770
  • Hillsborough, NJ
  • North Wildwood, NJ
  • Highland Park, NJ
  • Belle Mead, NJ

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    Graduate or professional degree

Emails

Us Patents

  • Nonpeptide Substituted Benzothiazepines As Vasopressin Antagonists

    view source
  • US Patent:
    6489321, Dec 3, 2002
  • Filed:
    Nov 2, 2000
  • Appl. No.:
    09/704314
  • Inventors:
    Maud J. Urbanski - Belle Mead NJ
    Robert H. K. Chen - Belle Mead NJ
  • Assignee:
    Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
  • International Classification:
    C07D28110
  • US Classification:
    51421105, 51421109, 540523, 540552
  • Abstract:
    The invention is directed to nonpeptide substituted benzodiazepines of Formula I, wherein A, X, Z, Bp, W, n, R and R are as described in the specification, which are useful as vasopressin receptor antagonists for treating conditions involving increased vascular resistance and cardiac insufficiency. Pharmaceutical compositions comprising a compound of Formula I and methods of treating conditions such as hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed.
  • Substituted Benzimidazol-2-Ones As Vasopressin Receptor Antagonists And Neuropeptide Y Modulators

    view source
  • US Patent:
    6653478, Nov 25, 2003
  • Filed:
    Oct 23, 2001
  • Appl. No.:
    10/047841
  • Inventors:
    Maud J. Urbanski - Flemington NJ
    Keith T. Demarest - Flemington NJ
  • Assignee:
    Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
  • International Classification:
    C07D40104
  • US Classification:
    546199, 546187, 514326, 514322
  • Abstract:
    The invention is directed to substituted benzimidazol-2-ones of Formula I, wherein A, X, Y, m, n, R , R , R , R , and R are as described in the specification, which are useful as vasopressin receptor antagonists or Neuropeptide Y Modulators for treating conditions such as aggression, obsessive-compulsive disorders, hypertension, dysmenorrhea, congestive heart failure/cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, edema, ischemia, stroke, thrombosis, water retention, nephrotic syndrome, central nervous injuries, obesity, anorexia, hyperglycemia, diabetes, anxiety, depression, asthma, memory loss, sexual dysfunction, disorders of sleep and other circadian rhythms, and Cushings disease.
  • Substituted Indazole-O-Glucosides

    view source
  • US Patent:
    7084124, Aug 1, 2006
  • Filed:
    Jul 30, 2004
  • Appl. No.:
    10/903034
  • Inventors:
    Mona Patel - Belle Mead NJ, US
    Philip J. Rybczynski - Branchburg NJ, US
    Maud Urbanski - Flemington NJ, US
    Xiaoyan Zhang - Belle Mead NJ, US
  • Assignee:
    Janssen Pharmaceutica, N.V. - Beerse
  • International Classification:
    A01N 43/04
    A61K 31/70
    C07H 15/00
    C07H 17/00
  • US Classification:
    514 27, 514 23, 514 25, 536 41, 536 172, 536 173, 536 174
  • Abstract:
    Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
  • Substituted Fused Heterocyclic C-Glycosides

    view source
  • US Patent:
    7094763, Aug 22, 2006
  • Filed:
    Jul 30, 2004
  • Appl. No.:
    10/903136
  • Inventors:
    Philip Rybczynski - Branchburg NJ, US
    Maud Urbanski - Flemington NJ, US
    Xiaoyan Zhang - Belle Mead NJ, US
  • Assignee:
    Janssen Pharaceutica, N.V.
  • International Classification:
    A01N 43/04
    A61K 31/70
    C07H 7/06
  • US Classification:
    514 23, 514866, 514909, 536 111, 536 187, 536 292, 536 53, 536 54, 536 55
  • Abstract:
    This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
  • Substituted Benzimidazole-, Benztriazole-, And Benzimidazolone-O-Glucosides

    view source
  • US Patent:
    7094764, Aug 22, 2006
  • Filed:
    Jul 30, 2004
  • Appl. No.:
    10/903234
  • Inventors:
    Maud Urbanski - Flemington NJ, US
  • Assignee:
    Janssen Pharmaceutica N.V. - Beerse
  • International Classification:
    A01N 43/04
    A61K 31/70
  • US Classification:
    514 23, 514 25, 514 27, 536 41, 536 172, 536 173, 536 174, 548257, 5483351
  • Abstract:
    This invention relates to to substituted benzimidazole-O-glucosides, benztriazole-O-glucosides, and benzimidazolone-O-glucosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
  • Substituted Indole-O-Glucosides

    view source
  • US Patent:
    7129220, Oct 31, 2006
  • Filed:
    Jul 30, 2004
  • Appl. No.:
    10/903233
  • Inventors:
    Mary Pat Beavers - New Hope PA, US
    Mona Patel - Belle Mead NJ, US
    Philip Rybczynski - Branchburg NJ, US
    Maud Urbanski - Flemington NJ, US
    Xiaoyan Zhang - Belle Mead NJ, US
  • Assignee:
    Janssen Pharmaceutica N.V
  • International Classification:
    A01N 43/04
    A61K 31/70
    C07H 15/00
    C07H 17/00
  • US Classification:
    514 27, 536 41, 536 172, 536 173, 536 174, 514 23, 514 25
  • Abstract:
    Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
  • Substituted Fused Heterocyclic C-Glycosides

    view source
  • US Patent:
    7482330, Jan 27, 2009
  • Filed:
    Jun 15, 2006
  • Appl. No.:
    11/453728
  • Inventors:
    Philip Rybczynski - Branchburg NJ, US
    Maud Urbanski - Flemington NJ, US
    Xiaoyan Zhang - Belle Mead NJ, US
  • Assignee:
    Janssen Pharmaceutica N.V. - Beerse
  • International Classification:
    A01N 43/04
    A61K 31/70
  • US Classification:
    514 23, 514866, 514909
  • Abstract:
    This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
  • Substituted Benzimidazole-, Benztriazole-, And Benzimidazolone-O-Glucosides

    view source
  • US Patent:
    7511020, Mar 31, 2009
  • Filed:
    Jun 15, 2006
  • Appl. No.:
    11/453727
  • Inventors:
    Maud Urbanski - Flemington NJ, US
  • Assignee:
    Janssen Pharmaceutica N.V. - Beerse
  • International Classification:
    A01N 43/04
    A61K 31/70
  • US Classification:
    514 25, 514 23, 514 27
  • Abstract:
    This invention relates to to substituted benzimidazole-O-glucosides, benztriazole-O-glucosides, and benzimidazolone-O-glucosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.

Resumes

Maud Urbanski Photo 1

Principal Scientist

view source
Location:
14 Mcpherson Dr, Flemington, NJ 08822
Work:

Principal Scientist
Maud Urbanski Photo 2

Maud Urbanski

view source

Facebook

Maud Urbanski Photo 3

Maud Urbanski Georges

view source
Friends:
Florian le Bidois, Vanessa Urbanski, Lorraine Heroult
Maud Urbanski Photo 4

Maud Urbanski

view source
Friends:
Okkan Demirtok, Marina Larsson, Moa quist, Tobias Mattsson
Maud Urbanski Photo 5

Maud Urbanski

view source
Friends: Okkan Demirtok, Marina Larsson, Moa quist, Lena Hellfrdsson, Tobias MattssonMaud Urbanski finns p Facebook. G med p Facebook fr att komma i kontakt ...

Get Report for Maud J Urbanski from Flemington, NJ, age ~71
Control profile